1 (Image 1)
Gabapentin
Product Images NDC 50090-2561
10 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-2561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
Gabapentin 100 mg capsules from A-S Medication Solutions. The image shows a white bottle with a white cap and a blue-bordered label. The label includes the product name Gabapentin, dosage strength 100 mg, and mentions capsules. Container details and NDC 50090-2561 are partially visible.*
1 (Image 3)
1 (Image 4)
Chemical structure of the active ingredient Gabapentin, as depicted in a molecular diagram showing its specific atomic and bond arrangement.*
1 (Image 5)
Chemical structure diagram of the active ingredient Gabapentin, showing a cyclohexane ring with attached amino and carboxymethyl functional groups.*
1 (Image 6)
A line graph depicting mean pain score over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The horizontal axis shows weeks divided into a 4-week dose titration period and a 4-week fixed dose period. Gabapentin results in a decreasing pain score over time, while placebo scores remain relatively stable.*
2 (Image 7)
A line graph showing mean pain score over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain score, ranging from 0 to 10. The graph shows decreasing pain scores for both Gabapentin dosages compared to placebo over time.*
3 (Image 8)
A bar chart comparing results from two studies labeled Study 1 and Study 2, showing percentages for placebo (PBO) and Gabapentin (GBP) at different doses (3600 mg in Study 1; 1800 mg and 2400 mg in Study 2). The chart includes statistical significance markers, indicating p-values less than 0.01 and 0.001 for the Gabapentin groups versus placebo.*
4 (Image 9)
A scatter plot graph displaying difference percentages on the vertical axis versus daily dose in milligrams on the horizontal axis. The graph compares three studies labeled a, b, and c, with data points at various doses ranging from 600 mg to 1800 mg. Each study is represented by distinct markers: black squares for study a, gray squares for study b, and white squares for study c.*
Label Image (Lbl500902561)
Gabapentin 100 mg capsule label from A-S Medication Solutions with Product NDC 50090-2561-0. The label states each capsule contains 100 mg gabapentin, storage instructions between 68 to 77 degrees Fahrenheit, and a package size of 30 capsules. It includes a lot number and barcode, along with labeling information for the manufacturer located in Libertyville, Illinois.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
